Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biocryst Pharma Inc
(NQ:
BCRX
)
8.100
+0.170 (+2.14%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biocryst Pharma Inc
< Previous
1
2
3
4
5
6
7
Next >
Unusual Options Activity Insight: BioCryst Pharmaceuticals
July 23, 2021
On Friday, shares of BioCryst Pharmaceuticals (NASDAQ:BCRX) saw unusual options activity. After the option alert, the stock price moved up to $17.1. Sentiment: BULLISH Option...
Via
Benzinga
BioCryst Outlines Pivotal Trial Designs For BCX9930 In Rare Blood Disorder
July 15, 2021
BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) has announced the designs for REDEEM-1 and REDEEM-2, two upcoming pivotal trials for its oral Factor D inhibitor,...
Via
Benzinga
BioCryst Shares 96-Week Orladeyo Data Highlighting 80% Reduction In HAE Attacks
July 12, 2021
BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) has announced 96-week data from the Phase 3 APeX-2 trial for Orladeyo (berotralstat), showing a sustained reduction in...
Via
Benzinga
18 Key Biopharma Catalysts To Keep An Eye On In Q3
July 10, 2021
Biopharma stocks underperformed in the first half of 2021, and several of these stocks could be in for a rebound in the coming months. Ne...
Via
Benzinga
Up 126% in 2021, Could BioCryst Pharmaceuticals Go Even Higher?
June 29, 2021
There's more than one opportunity for it to do so.
Via
The Motley Fool
Why BioCryst Pharmaceuticals' Stock Is Trading Higher Today
May 06, 2021
BioCryst Pharmaceuticals (NASDAQ:BCRX) shares are tra...
Via
Benzinga
9 Health Care Stocks With Unusual Options Alerts In Today's Session
June 22, 2021
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away...
Via
Benzinga
Analyzing BioCryst Pharmaceuticals's Unusual Options Activity
June 18, 2021
Shares of BioCryst Pharmaceuticals (NASDAQ:BCRX) saw some unusual options activity on Friday. Following the unusual option alert, the stock price moved down to $16.12. Sentiment...
Via
Benzinga
In Case Silver Gets Slammed More
June 18, 2021
The Fed is no longer your friend when it comes to silver. Time to consider limiting your downside risk here.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO
June 16, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 15) Apellis Pharmaceuticals,...
Via
Benzinga
Exposures
COVID-19
Product Safety
BioCryst's Orladeyo Application Under Review In Israel For Hereditary Angioedema
June 16, 2021
The Israeli Ministry of Health has accepted for review BioCryst Pharmaceuticals Inc's (NASDAQ: BCRX) application for Orladeyo to prevent recurrent attacks in...
Via
Benzinga
The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts
June 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 10) Alexion Pharmaceuticals,...
Via
Benzinga
The Daily Biotech Pulse: Hookipa, PDS Biotech Report Positive Data, Ironwood CFO To Depart, Decision Day For Vertex
June 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 7) Agios Pharmaceuticals, Inc...
Via
Benzinga
The Daily Biotech Pulse: Merck, AstraZeneca, Novartis Among Early Presenters At ASCO, Sanofi Strikes Breast Cancer Study Pact
June 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 3) BioCryst Pharmaceuticals,...
Via
Benzinga
The Daily Biotech Pulse: Merck Completes Organon Spin-Off, Auris Repositions As RNA Therapeutic Company With Trasir Purchase, Replimune's Readout
June 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 2) BioCryst Pharmaceuticals,...
Via
Benzinga
Stocks That Hit 52-Week Highs On Thursday
June 03, 2021
Before 10 a.m. ET on Thursday, 86 companies set new 52-week highs. Noteworthy Mentions: The largest company on a market cap basis to set a new 52-week high was Bank...
Via
Benzinga
The Daily Biotech Pulse: Biohaven, Bristol-Myers Squibb Snag FDA Approvals, Iterum UTI Drug Review On Track, Centessa Pharmaceuticals Debuts On Nasdaq
May 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 27) BioCryst Pharmaceuticals,...
Via
Benzinga
Exposures
Product Safety
Forget AMC, GameStop: Analyst Names 2 New Reddit Stocks Traders Should Watch
May 27, 2021
Meme stocks AMC Entertainment Holdings Inc (NYSE: AMC) and GameStop Corp. (NYSE: GME) are on the move once again this week, fueled by targeted buying campaigns driven by Reddit...
Via
Benzinga
Is BioCryst a Good Stock to Buy Now?
May 21, 2021
This commercial-stage drugmaker trades for less than many of its clinical-stage peers.
Via
The Motley Fool
Exposures
Product Safety
The Daily Biotech Pulse: Iovance To Delay Regulatory Filing For Cancer Therapy, Departures At Passage Bio, Positive Readout For Silence Therapeutics
May 19, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 18) Alexion Pharmaceuticals, Inc...
Via
Benzinga
The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO
May 18, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc...
Via
Benzinga
Exposures
COVID-19
Why BioCryst Pharmaceuticals Stock Is Jumping Today
May 17, 2021
Investors appear to be increasingly optimistic about the outlook for its drug Orladeyo.
Via
The Motley Fool
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
May 14, 2021
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...
Via
Benzinga
Is BioCryst Pharmaceuticals A Good Biotech Stock To Own?
May 12, 2021
Growing investor interest in the bio-pharmaceuticals industry, combined with various technology innovations leading to breakthrough drug trials, have allowed BCRX to generate $19.10 million in revenues...
Via
Talk Markets
72 Biggest Movers From Yesterday
May 07, 2021
Gainers SemiLEDs Corporation (NASDAQ: LEDS) shares surged 85.8% to settle at $10.22 on above-average volume. Liquidity Services, Inc. (NASDAQ: LQDT) jumped 37.7% to settle at $25...
Via
Benzinga
BioCryst Pharmaceuticals (BCRX) Q1 2021 Earnings Call Transcript
May 06, 2021
BCRX earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
12 Health Care Stocks Moving In Thursday's Intraday Session
May 06, 2021
Gainers Lexaria Bioscience (NASDAQ:LEXX) shares rose 53.87% to $7.74 during Thursday's regular session. As of 12:30 EST, Lexaria Bioscience's stock is trading at a...
Via
Benzinga
BioCryst Shares Trading Higher As Q1 Sales Beat Was Supported By Orladeyo Revenues
May 06, 2021
BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) reported a first-quarter loss of $0.36, wider than the consensus loss of $0.27 and deeper than the EPS loss of $0.24...
Via
Benzinga
Topics
Earnings
Exposures
Financial
Why BioCryst Pharmaceuticals Stock Is Soaring Today
May 06, 2021
The drugmaker reported better-than-expected Q1 results.
Via
The Motley Fool
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 06, 2021
Gainers Stealth BioTherapeutics (NASDAQ:MITO) stock moved upwards by 58.33% to $1.9 during Thursday's pre-market session. The market value of their outstanding shares...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.